Gene Expression Analysis Market

Gene Expression Analysis Market by Product Types (DNA Chip/Microarray, Kits & Reagent, and Others), Processes (cDNA Synthesis & Conversion, Data Analysis & Interpretation, PCR Analysis, Purification, and Sample Collection), Capacities (Low-to-Mid-Plex Gene Expression Analysis and High-Plex Gene Expression Analysis), Techniques (Promoter Analysis, Protein Exp. & Posttranslational Modification Analysis and RNA Exp.), Applications (Biotechnology & Microbiology, Clinical Diagnostics [RNA Exp.], Drug Discovery & Development, and Others), End-users (Academic Institutes & Research Centres, Pharmaceutical & Biotech Companies, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-4037
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global gene expression analysis market size is estimated to register a high CAGR during the forecast period, between 2021 and 2028. The growth of the market is attributed to the lowering of the cost of gene sequencing and rising demand for gene study for clinical research to enhance the treatment for several illness.

Gene Expression Analysis Market key takeaways

The approach of obtaining data from a gene to analyze the behaviour of biological systems is known as gene expression analysis (GEA). It includes some major processes such as gene translation, transcription, protein post-translational modification, and ribonucleic acid (RNA) splicing. The information gleaned from this examination is used to create RNA, proteins, and a variety of microbiological products. They are also used in the development of new medications and improvement of existing diagnostic systems. GEA is now widely regarded as critical healthcare method in explaining the mechanisms that can produce a wide range of medical treatment for various diseases, and as a result, it has multiple applications in bio marking, pharmacogenomics, diagnostics, and toxicology.

Market Trends, Drivers, Restraints, and Opportunities

  • Declining cost of sequencing and increasing genetic research to better understand the underlying causes of many disorders are key factors propelling the market.
  • Growing usage of targeted molecular therapies as well as the increasing need for personalized medicines are important drivers of the market.
  • Rising prevalence of chronic diseases such as TB, cancer, and cardiovascular and genetic problems is expected to boost the market significantly in the coming years.
  • Hybridization-based detection and the usage of predesigned oligonucleotides along with the scarcity of trained professionals are major challenges anticipated to hamper the market growth.
  • New drug discovery, technological development, as well as expanding research activities are projected to provide profitable growth opportunities for the market in the long run.

Scope of the report

The report on the global gene expression analysis market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Gene Expression Analysis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product Types (DNA Chip/Microarray, Kits & Reagent, and Others), Processes (cDNA Synthesis & Conversion, Data Analysis & Interpretation, PCR Analysis, Purification, and Sample Collection), Capacities (Low-to-Mid-Plex Gene Expression Analysis and High-Plex Gene Expression Analysis), Techniques (Promoter Analysis [Chromatin Immunoprecipitation Assays, Gel Shift Assays, and In Vitro Transcription/Nuclear Run-On Assays], Protein Exp. & Posttranslational Modification Analysis [2-D Gel Electrophoresis, Immunoassays, Mass Spectrometry, and Western Blotting], and RNA Exp. [DNA Microarrays, Northern Blotting, PCR Techniques, and RNA-Seq]), Applications (Biotechnology & Microbiology, Clinical Diagnostics [RNA Exp.], Drug Discovery & Development, and Others), End-users (Academic Institutes & Research Centres, Pharmaceutical & Biotech Companies, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Thermo Fisher Scientific; Promega Corporation; Bio-Rad Laboratories, Inc.; Takara Bio Inc.; PerkinElmer Inc.; Biocartis; QIAGEN; IntegraGen; Illumina, Inc.; and Interpace Biosciences, Inc.

 

Global Gene Expression Analysis Market Segment Insights

Kits & reagent segment is projected to hold significant market share

Based on product types, the global gene expression analysis market is divided into DNA chip/microarray, kits & reagent, and others. The kits & reagent segment is projected to hold significant market share owing to the presence of a large number of firms offering various types of kits and reagents for gene expression. In addition, the development of improved goods developed for specialized applications further propels the segment.

cDNA synthesis & conversion segment to account for substantial share

 On the basis of processes, the market is segmented into cDNA synthesis & conversion, data analysis & interpretation, PCR analysis, purification, and sample collection. The cDNA synthesis & conversion segment is anticipated to account for substantial share of the market due to the availability of a wide selection of cDNA synthesis kits to meet the study needs in terms of optimal reaction temperature, sample size, and a number of reactions. Furthermore, a surge in cDNA synthesis and library preparation kit product introductions is a key factor driving the segment.

Gene Expression Analysis Market by processes

High-plex gene expression analysis segment to register a substantial growth rate

In terms of capacities, the global gene expression analysis market is bifurcated into low-to-mid-plex gene expression analysis and high-plex gene expression analysis. The high-plex gene expression analysis segment is anticipated to register a substantial growth rate during the projection timeline. The segment growth is owing to the increase in the adoption of gene expression scrutiny, intended for various genomic research reviews. Furthermore, when compared to qPCR and other traditional technologies, high-plex analysis lowers hands-on time. The procedure is also highly accurate and easy since it eliminates the need for first probe validation. The introduction of spatially resolved coupled with multiplexed digital characterisation systems is likely to boost the segment further.

RNA exp. segment to expand at a robust pace

Based on techniques, the market is segregated into promoter analysis, protein exp. & posttranslational modification analysis, and RNA exp. The promoter analysis segment is further classified as chromatin immunoprecipitation assays, gel shift assays, and in vitro transcription/nuclear run-on assays. The protein exp. & posttranslational modification analysis segment is further divided into 2-d gel electrophoresis, immunoassays, mass spectrometry, and western blotting. Furthermore, the RNA exp. segment is sub-categorized as DNA microarrays, northern blotting, PCR techniques, and RNA-Seq. The RNA exp. segment is anticipated to expand at a robust pace in the coming years. High-throughput technologies, such as RNA sequencing (RNA-seq) and cDNA microarray that have been adopted frequently to replace prior procedures. As a result, technological developments in RNA extraction procedures and tools along with the availability of a variety of products to fulfil various research demands are further pushing to enhance the usage of these techniques for gene expression investigation.

Drug discovery & development segment to hold substantial market share

On the basis of applications, the global gene expression analysis market is fragmented into biotechnology & microbiology, clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment has its sub unit, RNA Exp. The drug discovery & development segment is estimated to hold substantial market share. A growth in the study of gene expression outlines of SARS-CoV-2 receptors for in silico drug innovation for COVID-19 is a significant driving force of the segment. An August 2020 study analysed gene expression patterns to investigate the key activities of Angiotensin-converting enzyme 2 (ACE2)-related genes.

Pharmaceutical & biotech companies segment to account for a key share

In terms of end-users, the market is segmented into academic institutes & research centres, pharmaceutical & biotech companies, and others. The pharmaceutical & biotech companies segment is projected to account for a key market share. Gene expression analysis products and services are used by pharmaceutical and biotechnology companies to meet clinical research goals such as medication development and discovery as well as biotech research. Biopharmaceutical businesses are primarily concerned with the development of targeted treatments, particularly for the treatment of complex diseases, cancer, and uncommon genetic abnormalities. Contract research organizations (CROs) provide a variety of gene expression analysis services including NGS gene expression profiling. This is increasing the need for CROs' gene expression analysis services.

North America is expected to dominate the market

In terms of regions, the global gene expression analysis market is categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market due to the wide research and development of gene therapy as well as favorable government initiatives encouraging robust clinical experiment for gene expression. Moreover, the emphasis on gene expression studies and the availability of funding for innovative technology for research from governments are propelling the gene expression analysis market in the region.

Gene Expression Analysis Market by regions

Segments

Segments Covered in the Report
The global gene expression analysis market has been segmented on the basis of

Product Types

  • DNA Chip/Microarray
  • Kits & Reagent
  • Others
Processes
  • cDNA Synthesis & Conversion
  • Data Analysis & Interpretation
  • PCR Analysis
  • Purification
  • Sample Collection
Capacities
  • Low-to-Mid-Plex Gene Expression Analysis
  • High-Plex Gene Expression Analysis
Techniques
  • Promoter Analysis
    • Chromatin Immunoprecipitation Assays
    • Gel Shift Assays
    • In Vitro Transcription/Nuclear Run-On Assays
  • Protein Exp. & Posttranslational Modification Analysis
    • 2-D Gel Electrophoresis
    • Immunoassays
    • Mass Spectrometry
    • Western Blotting
  • RNA Exp.
    • DNA Microarrays
    • Northern Blotting
    • PCR Techniques
    • RNA-Seq
Applications
  • Biotechnology & Microbiology
  • Clinical Diagnostics
    • RNA Exp.
  • Drug Discovery & Development
  • Others
End-users
  • Academic Institutes & Research Centres
  • Pharmaceutical & Biotech Companies
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • PerkinElmer Inc.
  • Biocartis
  • QIAGEN
  • IntegraGen
  • Illumina, Inc.
  • Interpace Biosciences, Inc.

Competitive Landscape

Key players competing in the global global gene expression analysis market are Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Thermo Fisher Scientific; Promega Corporation; Bio-Rad Laboratories, Inc.; Takara Bio Inc.; PerkinElmer Inc.; Biocartis; QIAGEN; IntegraGen; Illumina, Inc.; and Interpace Biosciences, Inc. These big players are constantly engaged in wide-ranging R&D operations to develop new methodologies and technologies for the gene expression analysis system or service to increase their market share.

Gene Expression Analysis Market  y key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gene Expression Analysis Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Gene Expression Analysis Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Gene Expression Analysis Market - Supply Chain
  4.5. Global Gene Expression Analysis Market Forecast
     4.5.1. Gene Expression Analysis Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Gene Expression Analysis Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Gene Expression Analysis Market Absolute $ Opportunity
5. Global Gene Expression Analysis Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Gene Expression Analysis Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Gene Expression Analysis Demand Share Forecast, 2019-2026
6. North America Gene Expression Analysis Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Gene Expression Analysis Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Gene Expression Analysis Demand Share Forecast, 2019-2026
7. Latin America Gene Expression Analysis Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Gene Expression Analysis Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Gene Expression Analysis Demand Share Forecast, 2019-2026
8. Europe Gene Expression Analysis Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Gene Expression Analysis Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Gene Expression Analysis Demand Share Forecast, 2019-2026
9. Asia Pacific Gene Expression Analysis Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Gene Expression Analysis Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Gene Expression Analysis Demand Share Forecast, 2019-2026
10. Middle East & Africa Gene Expression Analysis Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Gene Expression Analysis Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Gene Expression Analysis Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Gene Expression Analysis Market: Market Share Analysis
  11.2. Gene Expression Analysis Distributors and Customers
  11.3. Gene Expression Analysis Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Quest Diagnostics Incorporated
     11.4.2. Agilent Technologies, Inc.
     11.4.3. Thermo Fisher Scientific
     11.4.4. Promega Corporation
     11.4.5. Bio-Rad Laboratories, Inc.
     11.4.6. Takara Bio Inc.
     11.4.7. PerkinElmer Inc.

Segments Covered in the Report
The global gene expression analysis market has been segmented on the basis of

Product Types

  • DNA Chip/Microarray
  • Kits & Reagent
  • Others
Processes
  • cDNA Synthesis & Conversion
  • Data Analysis & Interpretation
  • PCR Analysis
  • Purification
  • Sample Collection
Capacities
  • Low-to-Mid-Plex Gene Expression Analysis
  • High-Plex Gene Expression Analysis
Techniques
  • Promoter Analysis
    • Chromatin Immunoprecipitation Assays
    • Gel Shift Assays
    • In Vitro Transcription/Nuclear Run-On Assays
  • Protein Exp. & Posttranslational Modification Analysis
    • 2-D Gel Electrophoresis
    • Immunoassays
    • Mass Spectrometry
    • Western Blotting
  • RNA Exp.
    • DNA Microarrays
    • Northern Blotting
    • PCR Techniques
    • RNA-Seq
Applications
  • Biotechnology & Microbiology
  • Clinical Diagnostics
    • RNA Exp.
  • Drug Discovery & Development
  • Others
End-users
  • Academic Institutes & Research Centres
  • Pharmaceutical & Biotech Companies
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • PerkinElmer Inc.
  • Biocartis
  • QIAGEN
  • IntegraGen
  • Illumina, Inc.
  • Interpace Biosciences, Inc.

Key players competing in the global global gene expression analysis market are Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Thermo Fisher Scientific; Promega Corporation; Bio-Rad Laboratories, Inc.; Takara Bio Inc.; PerkinElmer Inc.; Biocartis; QIAGEN; IntegraGen; Illumina, Inc.; and Interpace Biosciences, Inc. These big players are constantly engaged in wide-ranging R&D operations to develop new methodologies and technologies for the gene expression analysis system or service to increase their market share.

Gene Expression Analysis Market  y key players

Buy Report